FOMX - 3.09 Pre-market now at 3.20/3.30 Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea https://www.tradescores.com/StockReport/fomx